Suppr超能文献

幽门螺杆菌感染与胃腺癌

Helicobacter pylori Infection and Gastric Adenocarcinoma.

作者信息

Correa Pelayo, Piazuelo M Blanca

机构信息

Anne Potter Wilson Professor of Medicine, Vanderbilt University School of Medicine, Nashville.

出版信息

US Gastroenterol Hepatol Rev. 2011 Jun;7(1):59-64.

Abstract

Gastric adenocarcinoma is the second leading cause of cancer-related mortality worldwide. Infection with Helicobacter pylori is the strongest recognized risk factor for gastric adenocarcinoma. This bacterial species colonizes the stomach of more than half of the world's population; however, only a very small proportion of infected subjects develop adenocarcinoma. H. pylori causes a chronic gastritis that may last decades, and a multistep precancerous process is recognized for the most frequent histologic type of gastric adenocarcinoma: the intestinal type. The severity and long-term outcome of this infection is modulated by an increasing list of bacterial, host, and environmental factors, which interplay in a complex manner. Identification of individuals at high risk for gastric cancer that may enter a surveillance program and intervention during the precancerous process is the most suitable strategy for decreasing mortality due to this malignancy.

摘要

胃腺癌是全球癌症相关死亡的第二大主要原因。幽门螺杆菌感染是公认的胃腺癌最强风险因素。这种细菌在世界上超过一半人口的胃中定植;然而,只有极小比例的感染者会发展为腺癌。幽门螺杆菌会引发可能持续数十年的慢性胃炎,对于最常见的胃腺癌组织学类型——肠型,已确认存在一个多步骤的癌前过程。这种感染的严重程度和长期后果受到越来越多的细菌、宿主和环境因素的调节,这些因素以复杂的方式相互作用。识别可能进入监测程序并在癌前过程中进行干预的胃癌高危个体,是降低这种恶性肿瘤死亡率的最合适策略。

相似文献

1
Helicobacter pylori Infection and Gastric Adenocarcinoma.
US Gastroenterol Hepatol Rev. 2011 Jun;7(1):59-64.
2
AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review.
Gastroenterology. 2025 Feb;168(2):405-416.e1. doi: 10.1053/j.gastro.2024.11.001. Epub 2024 Dec 23.
3
Helicobacter pylori and gastric cancer: factors that modulate disease risk.
Clin Microbiol Rev. 2010 Oct;23(4):713-39. doi: 10.1128/CMR.00011-10.
4
Helicobacter pylori: the link with gastric cancer.
Eur J Cancer Prev. 1994 May;3(3):247-57. doi: 10.1097/00008469-199403030-00003.
5
[Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].
Arq Gastroenterol. 2007 Apr-Jun;44(2):93-8. doi: 10.1590/s0004-28032007000200002.
6
Host pathogen interactions in related gastric cancer.
World J Gastroenterol. 2017 Mar 7;23(9):1521-1540. doi: 10.3748/wjg.v23.i9.1521.
7
Helicobacter pylori and gastric neoplasia.
Contrib Microbiol. 2006;13:66-80. doi: 10.1159/000092966.
9
Role of Helicobacter pylori infection in pathogenesis of gastric carcinoma.
World J Gastrointest Pathophysiol. 2016 Feb 15;7(1):97-107. doi: 10.4291/wjgp.v7.i1.97.
10
From inflammation to gastric cancer: Role of .
Oncol Lett. 2017 Feb;13(2):543-548. doi: 10.3892/ol.2016.5506. Epub 2016 Dec 15.

引用本文的文献

1
Cost-utility of endoscopic screening strategies for upper gastrointestinal cancer across China: a modeling study.
Front Public Health. 2025 Aug 14;13:1643171. doi: 10.3389/fpubh.2025.1643171. eCollection 2025.
2
Autophagy-driven modulation of stem cell dynamics in -induced gastric diseases in mice.
Virulence. 2025 Dec;16(1):2551176. doi: 10.1080/21505594.2025.2551176. Epub 2025 Sep 1.
4
Chronic Atrophic Gastritis and Intestinal Metaplasia: A Latin American Perspective.
Korean J Helicobacter Up Gastrointest Res. 2024 Sep;24(3):218-230. doi: 10.7704/kjhugr.2024.0017. Epub 2024 Sep 9.
6
The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications.
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251331960. doi: 10.1177/15330338251331960. Epub 2025 Apr 10.
7
Mutations that accrue through life set the stage for stomach cancer.
Nature. 2025 Apr;640(8058):322-323. doi: 10.1038/d41586-025-00803-y.
8
Traditional Chinese medicine for chronic atrophic gastritis: Efficacy, mechanisms and targets.
World J Gastroenterol. 2025 Mar 7;31(9):102053. doi: 10.3748/wjg.v31.i9.102053.
9
The Protective Role of DDIT4 in Helicobacter pylori-induced Gastric Metaplasia Through Metabolic Regulation of Ferroptosis.
Cell Mol Gastroenterol Hepatol. 2025;19(5):101448. doi: 10.1016/j.jcmgh.2024.101448. Epub 2024 Dec 27.

本文引用的文献

1
Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk.
Gut. 2011 Sep;60(9):1189-95. doi: 10.1136/gut.2010.234468. Epub 2011 Feb 25.
2
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
3
Role of innate immunity in Helicobacter pylori-induced gastric malignancy.
Physiol Rev. 2010 Jul;90(3):831-58. doi: 10.1152/physrev.00039.2009.
4
Cancer statistics, 2010.
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
6
The enigma of Helicobacter pylori infection and gastric cancer.
Indian J Gastroenterol. 2010 Jun;29(3):95-100. doi: 10.1007/s12664-010-0024-1. Epub 2010 Jun 29.
7
Helicobacter pylori: gastric cancer and beyond.
Nat Rev Cancer. 2010 Jun;10(6):403-14. doi: 10.1038/nrc2857.
8
Pathology of gastric intestinal metaplasia: clinical implications.
Am J Gastroenterol. 2010 Mar;105(3):493-8. doi: 10.1038/ajg.2009.728.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验